Synthomer (LON:SYNT - Get Free Report) had its price objective lowered by equities research analysts at Deutsche Bank Aktiengesellschaft from GBX 140 ($1.86) to GBX 115 ($1.52) in a research note issued to investors on Wednesday,
London Stock Exchange reports. The firm currently has a "hold" rating on the stock. Deutsche Bank Aktiengesellschaft's price objective points to a potential upside of 36.09% from the company's current price.
Synthomer Price Performance
Shares of SYNT traded up GBX 0.10 ($0.00) during trading hours on Wednesday, hitting GBX 84.50 ($1.12). 636,605 shares of the company were exchanged, compared to its average volume of 692,609. The company has a market capitalization of £138.56 million, a PE ratio of -1.69, a PEG ratio of -0.17 and a beta of 1.79. The company has a debt-to-equity ratio of 78.27, a current ratio of 1.90 and a quick ratio of 0.97. The firm has a fifty day simple moving average of GBX 103.37 and a 200-day simple moving average of GBX 112.45. Synthomer has a one year low of GBX 78.20 ($1.04) and a one year high of GBX 276.50 ($3.67).
Insiders Place Their Bets
In other Synthomer news, insider Janet E. Ashdown acquired 19,920 shares of the company's stock in a transaction dated Thursday, July 3rd. The shares were acquired at an average cost of GBX 99 ($1.31) per share, for a total transaction of £19,720.80 ($26,147.97). 28.00% of the stock is currently owned by company insiders.
About Synthomer
(
Get Free Report)
Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.
Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.